89 results on '"Kolb, Todd M."'
Search Results
2. Vascular endothelial growth factor receptor 2 contributes to shear stress-induced endothelial nitric oxide synthase expression in human lung microvascular endothelial cells
3. Shear Stress Induces Morphology Changes in Human Lung Microvascular Endothelial Cells via Calcium Influx
4. A Novel Interaction Between Aquaporin 1 and Caspase-3 in Pulmonary Arterial Smooth Muscle Cells
5. Quantifying 4D flow cardiovascular magnetic resonance vortices in patients with pulmonary hypertension: A pilot study
6. Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension
7. MK2 nonenzymatically promotes nuclear translocation of caspase-3 and resultant apoptosis
8. Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension
9. Tumor MK2 transcript levels are associated with improved response to chemotherapy and patient survival in non-small cell lung cancer
10. Improved Survival for Patients with Systemic Sclerosis–associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry
11. Risk assessment of systemic sclerosis-associated pulmonary arterial hypertension: cardiac indexversusstroke volume index
12. Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
13. Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis
14. How We Would Treat Our Own Pulmonary Hypertension if We Needed to Undergo Cardiac Surgery
15. Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
16. Left Atrial Ablation for the Management of Atrial Tachyarrhythmias in Patients with Pulmonary Hypertension: A Case Series
17. Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension
18. Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study
19. Pulmonary Hypertension Associated with Respiratory Disease
20. PDE9A deficiency does not prevent chronic‐hypoxic pulmonary hypertension in mice
21. Right ventricular function as assessed by cardiac magnetic resonance imaging‐derived strain parameters compared to high‐fidelity micromanometer catheter measurements
22. Anesthetic techniques for patients with pulmonary hypertension undergoing ophthalmologic procedures: A case series
23. Associations of Angiopoietins With Heart Failure Incidence and Severity
24. A novel approach to perioperative risk assessment for patients with pulmonary hypertension
25. Exercise right ventricular ejection fraction predicts right ventricular contractile reserve
26. Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop
27. Pulmonary Hypertension Associated with Respiratory Diseases
28. Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
29. Treatment of Pulmonary Hypertension
30. Kussmaul’s Sign in Pulmonary Hypertension Corresponds With Severe Pulmonary Vascular Pathology Rather Than Right Ventricular Diastolic Dysfunction
31. Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survival
32. Risk assessment in Scleroderma-associated pulmonary arterial hypertension
33. Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD
34. Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension
35. Functional Impact of Human Genetic Variants of COL18A1/Endostatin on Pulmonary Endothelium
36. Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis‐related pulmonary arterial hypertension
37. SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model
38. Disconnect between Fibrotic Response and Right Ventricular Dysfunction
39. A nonapoptotic endothelial barrier-protective role for caspase-3
40. Discordance between Imaging Modalities in the Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Combined Experience from Two Academic Medical Centers
41. Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension
42. Supply and Demand: Micro(vascular) Economics of the Right Ventricle in Pulmonary Hypertension
43. Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model
44. Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement
45. Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?
46. Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report
47. Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension
48. Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact
49. Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease
50. Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.